|
|
News Breaks | | | | November 28, 2012 | | 10:48 EDT |  | TEA, SBUX | Teavana down 1% after Glaucus reiterates Strong Sell rating
Short selling research firm Glaucus issued a second report on Teavana (TEA) this morning where the firm reiterated its Strong Sell rating on the stock. Glaucus Research explained in greater detail the independent laboratory tests it used to show that Teavana’s teas contain pesticides in amounts that exceed U.S. and EU regulatory limits. The firm argues Teavana deceived Starbucks (SBUX), the company's prospective acquirer. Teavana shares are down 1.2%, or 18c, to $14.70 in mid-morning trading. Reference Link | |
|
News For TEA;SBUX From The Last 14 Days Check below for free stories on TEA;SBUX the last two weeks. |
|
|
| June 17, 2013 | | 07:23 EDT |  | SBUX | Jefferies to host a conference
 Subscribe for More Information | | | June 7, 2013 | | 09:49 EDT |  | SBUX | Starbucks Q3 revenue estimate below the Street at ITG Research
ITG Research initiated its Q3 Starbucks estimate at $335M, below the Street's $349M estimate. | |
|
|
|
|
|
|
